'use strict';
var app = angular.module('angularApp')
.controller('KeywordSearchCtrl', function (keywordService,utilsService,navigationService,groupService,$scope,$rootScope,$filter,ngTableParams,$http,$location,$modal) {
	$rootScope.tabs = navigationService.get();
	$rootScope.groups = groupService.getGroups.data.get();
	$scope.keywordData = keywordService.keywordData.data;
	$scope.loggedInUser = groupService.getUserName();
	$scope.utilsService = utilsService;
	// $scope.tabs.userLoggedIn = true;
	// $scope.keywordData = [{"type":"protocol","name":"JSTA_JFCR_NEC_FHU_TUSM_NIAIST-JMiyawakiAN2009-01","createdDate":"201003051550","description":"This nanoparticle is described in\r\nMiyawaki J, Matsumura S, Yuge R, Murakami T, Sato S, Tomida A, Tsuruo T, Ichihashi T, Fujinami T, Irie H, Tsuchida K, Iijima S, Shiba K, Yudasaka M.\r\nBiodistribution and ultrastructural localization of single-walled carbon nanohorns determined in vivo with embedded Gd2O3 labels.\r\nACS Nano  3:1399-1406 (2009).\r\n\r\nSingle wall nanohorn aggregate with embedded gadolinium oxide","id":"15368250","pubmedId":"abc123","fileId":"1232","fileTitle":"This is a file title","editable":false},{"type":"publication","name":"KU_JSTC-TKawanoBC2009-01","createdDate":"200905281554","description":"This nanoparticle is described in\r\nKawano T, Niidome Y, Mori T, Katayama Y, Niidome T. \r\nPNIPAM gel-coated gold nanorods for targeted delivery responding to a near-infrared laser.\r\nBioconjug Chem 20:209-212 (2009).\r\n\r\nSilica-coated gold nanorod with thermo-responsive polymer shell","id":"13041670","pubmedId":"abc123","fileId":"fileid","fileTitle":null,"editable":true},{"type":"sample","name":"JSTA_FHU_NEC_MU_AIST-KAjimaAN2008-02","createdDate":"200907271840","description":"This nanoparticle is described in \r\nAjima K, Murakami T, Mizoguchi Y, Tsuchida K, Ichihashi T, Iijima S, Yudasaka M.\r\nEnhancement of in vivo anticancer effects of cisplatin by incorporation inside\r\nsingle-wall carbon nanohorns.\r\nACS Nano 2:2057-64 (2008).\r\n\r\nSingle wall carbon nanohorn with open holes and drug incorporated inside nanohorn","id":"13041664","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"JSTA_FHU_NEC_MU_AIST-KAjimaAN2008-01","createdDate":"200908111353","description":"This nanoparticle is described in \r\nAjima K, Murakami T, Mizoguchi Y, Tsuchida K, Ichihashi T, Iijima S, Yudasaka M.\r\nEnhancement of in vivo anticancer effects of cisplatin by incorporation inside\r\nsingle-wall carbon nanohorns.\r\nACS Nano 2:2057-64 (2008).\r\n\r\nSingle wall carbon nanohorn with open holes\r\n","id":"13041744","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"UM-IMajorosBM2006-01","createdDate":"200902101735","description":"This nanoparticle is described in\r\nMajoros IJ, Myc A, Thomas T, Mehta CB, and Baker JR\r\nPAMAM Dendrimer-Based Multifunctional Conjugate for Cancer\r\nTherapy: Synthesis, Characterization, and Functionality\r\nBiomacromolecules 7:572-579 (2006).\r\n\r\nPAMAM dendrimer","id":"10780757","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"UM-IMajorosBM2006-02","createdDate":"200902101849","description":"This nanoparticle is described in\r\nMajoros IJ, Myc A, Thomas T, Mehta CB, and Baker JR\r\nPAMAM Dendrimer-Based Multifunctional Conjugate for Cancer\r\nTherapy: Synthesis, Characterization, and Functionality\r\nBiomacromolecules 7:572-579 (2006).\r\n\r\nAcetylated PAMAM dendrimer","id":"10780758","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"KU_JSTC-TNiidomeJCR2006-02","createdDate":"200905262029","description":"This nanoparticle is described in\r\nNiidome T, Yamagata M, Okamoto Y, Akiyama Y, Takahashi H, Kawano T, Katayama Y, Niidome Y\r\nPEG-modified gold nanorods with a stealth character for in vivo applications\r\nJ Control Release 114:343-347 (2006).\r\n\r\nGold nanorod coated with PEG\r\n\r\nComposition data are in part from \r\nNiidome Y, Nishioka K, Kawasaki H, Yamada S.\r\nRapid synthesis of gold nanorods by the combination of chemical reduction\r\nand photoirradiation processes; morphological changes depending on the growing processes\r\nChem Commun 2376-7 (2003).","id":"12320769","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"KU_JSTC-TNiidomeJCR2006-01","createdDate":"200905071547","description":"This nanoparticle is described in\r\nNiidome T, Yamagata M, Okamoto Y, Akiyama Y, Takahashi H, Kawano T, Katayama Y, Niidome Y\r\nPEG-modified gold nanorods with a stealth character for in vivo applications\r\nJ Control Release 114:343-347 (2006).\r\n\r\nGold nanorod coated with cationic surfactant\r\n\r\nComposition data are in part from \r\nNiidome Y, Nishioka K, Kawasaki H, Yamada S.\r\nRapid synthesis of gold nanorods by the combination of chemical reduction\r\nand photoirradiation processes; morphological changes depending on the growing processes Chem Commun 2376-7 (2003).","id":"12320768","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"BB_SH_KCI_DFCI_WCMC_BWH_MIT-JHrkachSTM2012-02","createdDate":"201209251654","description":"This nanoparticle is described in \r\nHrkach J, Von Hoff D, Mukkaram Ali M, Andrianova E, Auer J, Campbell T, De Witt D, Figa M, Figueiredo M, \r\nHorhota A, Low S, McDonnell K, Peeke E, Retnarajan B, Sabnis A, Schnipper E, Song JJ, Song YH, Summa J, \r\nTompsett D, Troiano G, Van Geen Hoven T, Wright J, LoRusso P, Kantoff PW, Bander NH, Sweeney C, \r\nFarokhzad OC, Langer R, Zale S. Preclinical development and clinical translation of a PSMA-targeted docetaxel\r\nnanoparticle with a differentiated pharmacological profile. Sci Transl Med 4:128ra39 (2012).\r\n\r\nCopolymer nanoparticle with encapsulated drug and attached targeting copolymer","id":"35487747","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"BB_SH_KCI_DFCI_WCMC_BWH_MIT-JHrkachSTM2012-05","createdDate":"201209251654","description":"This nanoparticle is described in \r\nHrkach J, Von Hoff D, Mukkaram Ali M, Andrianova E, Auer J, Campbell T, De Witt D, Figa M, Figueiredo M, \r\nHorhota A, Low S, McDonnell K, Peeke E, Retnarajan B, Sabnis A, Schnipper E, Song JJ, Song YH, Summa J, \r\nTompsett D, Troiano G, Van Geen Hoven T, Wright J, LoRusso P, Kantoff PW, Bander NH, Sweeney C, \r\nFarokhzad OC, Langer R, Zale S. Preclinical development and clinical translation of a PSMA-targeted docetaxel\r\nnanoparticle with a differentiated pharmacological profile. Sci Transl Med 4:128ra39 (2012).\r\n\r\nCopolymer nanoparticle with encapsulated drug and attached targeting copolymer labeled with radioisotope","id":"35487750","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"BB_SH_KCI_DFCI_WCMC_BWH_MIT-JHrkachSTM2012-06","createdDate":"201209251654","description":"This nanoparticle is described in \r\nHrkach J, Von Hoff D, Mukkaram Ali M, Andrianova E, Auer J, Campbell T, De Witt D, Figa M, Figueiredo M, \r\nHorhota A, Low S, McDonnell K, Peeke E, Retnarajan B, Sabnis A, Schnipper E, Song JJ, Song YH, Summa J, \r\nTompsett D, Troiano G, Van Geen Hoven T, Wright J, LoRusso P, Kantoff PW, Bander NH, Sweeney C, \r\nFarokhzad OC, Langer R, Zale S. Preclinical development and clinical translation of a PSMA-targeted docetaxel\r\nnanoparticle with a differentiated pharmacological profile. Sci Transl Med 4:128ra39 (2012).\r\n\r\nCopolymer nanoparticle with encapsulated drug labeled with radioisotope and attached targeting copolymer","id":"35487751","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"BB_SH_KCI_DFCI_WCMC_BWH_MIT-JHrkachSTM2012-07","createdDate":"201209251654","description":"This nanoparticle is described in \r\nHrkach J, Von Hoff D, Mukkaram Ali M, Andrianova E, Auer J, Campbell T, De Witt D, Figa M, Figueiredo M, \r\nHorhota A, Low S, McDonnell K, Peeke E, Retnarajan B, Sabnis A, Schnipper E, Song JJ, Song YH, Summa J, \r\nTompsett D, Troiano G, Van Geen Hoven T, Wright J, LoRusso P, Kantoff PW, Bander NH, Sweeney C, \r\nFarokhzad OC, Langer R, Zale S. Preclinical development and clinical translation of a PSMA-targeted docetaxel\r\nnanoparticle with a differentiated pharmacological profile. Sci Transl Med 4:128ra39 (2012).\r\n\r\nCopolymer nanoparticle","id":"35487752","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"BB_SH_KCI_DFCI_WCMC_BWH_MIT-JHrkachSTM2012-08","createdDate":"201209251654","description":"This nanoparticle is described in \r\nHrkach J, Von Hoff D, Mukkaram Ali M, Andrianova E, Auer J, Campbell T, De Witt D, Figa M, Figueiredo M, \r\nHorhota A, Low S, McDonnell K, Peeke E, Retnarajan B, Sabnis A, Schnipper E, Song JJ, Song YH, Summa J, \r\nTompsett D, Troiano G, Van Geen Hoven T, Wright J, LoRusso P, Kantoff PW, Bander NH, Sweeney C, \r\nFarokhzad OC, Langer R, Zale S. Preclinical development and clinical translation of a PSMA-targeted docetaxel\r\nnanoparticle with a differentiated pharmacological profile. Sci Transl Med 4:128ra39 (2012).\r\n\r\nCopolymer nanoparticle","id":"35487753","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"Test_BB_SH_KCI_DFCI_WCMC_BWH_MIT-JHrkachSTM2012-02_as_Cura","createdDate":"201209251654","description":"This nanoparticle is described in \r\nHrkach J, Von Hoff D, Mukkaram Ali M, Andrianova E, Auer J, Campbell T, De Witt D, Figa M, Figueiredo M, \r\nHorhota A, Low S, McDonnell K, Peeke E, Retnarajan B, Sabnis A, Schnipper E, Song JJ, Song YH, Summa J, \r\nTompsett D, Troiano G, Van Geen Hoven T, Wright J, LoRusso P, Kantoff PW, Bander NH, Sweeney C, \r\nFarokhzad OC, Langer R, Zale S. Preclinical development and clinical translation of a PSMA-targeted docetaxel\r\nnanoparticle with a differentiated pharmacological profile. Sci Transl Med 4:128ra39 (2012).\r\n\r\nCopolymer nanoparticle with encapsulated drug and attached targeting copolymer","id":"41517060","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"new test","createdDate":"201209251654","description":"This nanoparticle is described in \r\nHrkach J, Von Hoff D, Mukkaram Ali M, Andrianova E, Auer J, Campbell T, De Witt D, Figa M, Figueiredo M, \r\nHorhota A, Low S, McDonnell K, Peeke E, Retnarajan B, Sabnis A, Schnipper E, Song JJ, Song YH, Summa J, \r\nTompsett D, Troiano G, Van Geen Hoven T, Wright J, LoRusso P, Kantoff PW, Bander NH, Sweeney C, \r\nFarokhzad OC, Langer R, Zale S. Preclinical development and clinical translation of a PSMA-targeted docetaxel\r\nnanoparticle with a differentiated pharmacological profile. Sci Transl Med 4:128ra39 (2012).\r\n\r\nCopolymer nanoparticle with encapsulated drug and attached targeting copolymer","id":"42467336","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"GT_EM-AAgrawalAC2006-01","createdDate":"200809261303","description":"This nanoparticle is described in\r\nAgrawal A, Zhang C, Byassee T, Tripp RA, Nie S\r\nCounting Single Native Biomolecules and Intact\r\nViruses with Color-Coded Nanoparticles\r\nAnal Chem 78:1061-1070 (2006).\r\n\r\nPolystyrene nanoparticle and fluorescent oligonucleotide conjugate.","id":"5603330","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"GT_EM-AAgrawalAC2006-02","createdDate":"200809261304","description":"This nanoparticle is described in\r\nAgrawal A, Zhang C, Byassee T, Tripp RA, Nie S\r\nCounting Single Native Biomolecules and Intact\r\nViruses with Color-Coded Nanoparticles\r\nAnal Chem 78:1061-1070 (2006).\r\n\r\nCarboxyl group functionalized green fluorescent polystyrene nanoparticle  \r\nand oligonucleotide conjugate.","id":"5603331","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"GT_EM-AAgrawalAC2006-03","createdDate":"200809261307","description":"This nanoparticle is described in\r\nAgrawal A, Zhang C, Byassee T, Tripp RA, Nie S\r\nCounting Single Native Biomolecules and Intact\r\nViruses with Color-Coded Nanoparticles\r\nAnal Chem 78:1061-1070 (2006).\r\n\r\nCarboxyl group functionalized green fluorescent polystyrene nanoparticle and oligonucleotide conjugate.","id":"5603332","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"GT_EM-AAgrawalAC2006-04","createdDate":"200809261308","description":"This nanoparticle is described in\r\nAgrawal A, Zhang C, Byassee T, Tripp RA, Nie S\r\nCounting Single Native Biomolecules and Intact\r\nViruses with Color-Coded Nanoparticles\r\nAnal Chem 78:1061-1070 (2006).\r\n\r\nCarboxyl group functionalized green fluorescent polystyrene nanoparticle\r\nand oligonucleotide conjugate.","id":"5603333","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"GT_EM-AAgrawalAC2006-05","createdDate":"200809261310","description":"This nanoparticle is described in\r\nAgrawal A, Zhang C, Byassee T, Tripp RA, Nie S\r\nCounting Single Native Biomolecules and Intact\r\nViruses with Color-Coded Nanoparticles\r\nAnal Chem 78:1061-1070 (2006).\r\n\r\nCarboxyl group functionalized red fluorescent polystyrene nanoparticle and oligonucleotide conjugate.","id":"5603334","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"GT_EM-AAgrawalAC2006-06","createdDate":"200809261311","description":"This nanoparticle is described in\r\nAgrawal A, Zhang C, Byassee T, Tripp RA, Nie S\r\nCounting Single Native Biomolecules and Intact\r\nViruses with Color-Coded Nanoparticles\r\nAnal Chem 78:1061-1070 (2006).\r\n\r\nCarboxyl group functionalized green fluorescent polystyrene nanoparticle \r\nconjugated with capture antibody, tumor necrosis factor alpha,\r\nand biotinylated monoclonal antibody.","id":"5603335","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"GT_EM-AAgrawalJAFC2007-01","createdDate":"200809261742","description":"This nanoparticle is described in\r\nAgrawal A, Sathe T, Nie S\r\nSingle-Bead Immunoassays Using Magnetic Microparticles and\r\nSpectral-Shifting Quantum Dots\r\nJ Agric Food Chem 55:3778-3782 (2007).\r\n\r\nQuantum dot and murine monoclonal antibody conjugate","id":"6356992","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"GT_EM-AAgrawalJAFC2007-02","createdDate":"200809261743","description":"This nanoparticle is described in\r\nAgrawal A, Sathe T, Nie S\r\nSingle-Bead Immunoassays Using Magnetic Microparticles and\r\nSpectral-Shifting Quantum Dots\r\nJ Agric Food Chem 55:3778-3782 (2007).\r\n\r\nQuantum dot and murine monoclonal antibody conjugate","id":"6356993","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"CP_UCLA_Caltech-TSchluepPNAS2009-02","createdDate":"200910061513","description":"This nanoparticle is described in \r\nSchluep T, Hwang J, Hildebrandt IJ, Czernin J, Choi CH, Alabi CA, Mack BC, Davis ME.\r\nPharmacokinetics and tumor dynamics of the nanoparticle IT-101 from PET imaging and tumor histological measurements.\r\nProc Natl Acad Sci U S A  106:11394-9 (2009).\r\n\r\nLinear copolymer of cyclodextrin and PEG complexed with fluorescent drug","id":"6979614","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"CP_UCLA_Caltech-TSchluepPNAS2009-04","createdDate":"200910061429","description":"This nanoparticle is described in \r\nSchluep T, Hwang J, Hildebrandt IJ, Czernin J, Choi CH, Alabi CA, Mack BC, Davis ME.\r\nPharmacokinetics and tumor dynamics of the nanoparticle IT-101 from PET imaging and tumor histological measurements.\r\nProc Natl Acad Sci U S A  106:11394-9 (2009).\r\n\r\nGold nanoparticle coated with PEG and adamantanemethylamine (50%)","id":"6979615","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"NIOSH-VWalkerTAP2009-02","createdDate":"200910072029","description":"This nanoparticle is described in\r\nWalker VG, Li Z, Hulderman T, Schwegler-Berry D, Kashon ML, Simeonova PP.\r\nPotential in vitro effects of carbon nanotubes on human aortic endothelial cells.\r\nToxicol Appl Pharmacol 236:319-28 (2009).\r\n\r\nSingle wall carbon nanotube","id":"6979617","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"GT_EM-AAgrawalAC2006-07","createdDate":"200809261312","description":"This nanoparticle is described in\r\nAgrawal A, Zhang C, Byassee T, Tripp RA, Nie S\r\nCounting Single Native Biomolecules and Intact\r\nViruses with Color-Coded Nanoparticles\r\nAnal Chem 78:1061-1070 (2006).\r\n\r\nStreptavidin-coated red fluorescent polystyrene nanoparticle.","id":"9142323","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"GT_EM-AAgrawalAC2006-08","createdDate":"200809261314","description":"This nanoparticle is described in\r\nAgrawal A, Zhang C, Byassee T, Tripp RA, Nie S\r\nCounting Single Native Biomolecules and Intact\r\nViruses with Color-Coded Nanoparticles\r\nAnal Chem 78:1061-1070 (2006).\r\n\r\nCarboxyl group functionalized green fluorescent polystyrene nanoparticle\r\nand murine monoclonal antibody conjugate.","id":"9142324","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"GT_EM-AAgrawalAC2006-09","createdDate":"200809261314","description":"This nanoparticle is described in\r\nAgrawal A, Zhang C, Byassee T, Tripp RA, Nie S\r\nCounting Single Native Biomolecules and Intact\r\nViruses with Color-Coded Nanoparticles\r\nAnal Chem 78:1061-1070 (2006).\r\n\r\nCarboxyl group functionalized red polystyrene nanoparticle\r\nand murine monoclonal antibody conjugate.","id":"9142325","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"GT_EM-AAgrawalJAFC2007-03","createdDate":"200809261748","description":"This nanoparticle is described in\r\nAgrawal A, Sathe T, Nie S\r\nSingle-Bead Immunoassays Using Magnetic Microparticles and\r\nSpectral-Shifting Quantum Dots\r\nJ Agric Food Chem 2007;55:3778-3782.\r\n\r\nCarboxyl group functionalized yellow/green fluorescent \r\npolystyrene nanoparticle and monoclonal antibody conjugate.","id":"9142326","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"CP_UCLA_Caltech-TSchluepPNAS2009-01","createdDate":"200910052044","description":"This nanoparticle is described in \r\nSchluep T, Hwang J, Hildebrandt IJ, Czernin J, Choi CH, Alabi CA, Mack BC, Davis ME.\r\nPharmacokinetics and tumor dynamics of the nanoparticle IT-101 from PET imaging and tumor histological measurements.\r\nProc Natl Acad Sci U S A  106:11394-9 (2009).\r\n\r\nLinear copolymer of cyclodextrin and PEG","id":"9994260","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"NIOSH-VWalkerTAP2009-03","createdDate":"200910072034","description":"This nanoparticle is described in\r\nWalker VG, Li Z, Hulderman T, Schwegler-Berry D, Kashon ML, Simeonova PP.\r\nPotential in vitro effects of carbon nanotubes on human aortic endothelial cells.\r\nToxicol Appl Pharmacol 236:319-28 (2009).\r\n\r\nMultiwall carbon nanotube","id":"9994264","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"STANFORD-ZLiuACIEE-2007-01","createdDate":"200812291404","description":"This nanoparticle is described in\r\nLiu Z, Winters M, Holodniy M, Dai H\r\nsiRNA delivery into human T cells and primary cells with carbon-nanotube transporters\r\nAngew Chem Int Ed Engl 46:2023-2027 (2007).\r\n\r\nSingle wall carbon nanotube functionalized with polymer coat\r\n","id":"10780712","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"STANFORD-ZLiuACIEE-2007-02","createdDate":"200812291416","description":"This nanoparticle is described in\r\nLiu Z, Winters M, Holodniy M, Dai H\r\nsiRNA delivery into human T cells and primary cells with carbon-nanotube transporters\r\nAngew Chem Int Ed Engl 46:2023-2027 (2007).\r\n\r\nSingle wall carbon nanotube functionalized with polymer coat","id":"10780713","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"STANFORD-ZLiuACIEE-2007-03","createdDate":"200812291419","description":"This nanoparticle is described in\r\nLiu Z, Winters M, Holodniy M, Dai H\r\nsiRNA delivery into human T cells and primary cells with carbon-nanotube transporters\r\nAngew Chem Int Ed Engl 46:2023-2027 (2007).\r\n\r\nSingle wall carbon nanotube functionalized with polymer coat","id":"10780714","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"STANFORD-ZLiuACIEE-2007-06","createdDate":"200812291614","description":"This nanoparticle is described in\r\nLiu Z, Winters M, Holodniy M, Dai H\r\nsiRNA delivery into human T cells and primary cells with carbon-nanotube transporters\r\nAngew Chem Int Ed Engl 46:2023-2027 (2007).\r\n\r\nSingle wall carbon nanotube functionalized with polymer coat and attached siRNA","id":"10780717","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"STANFORD-ZLiuACIEE-2007-07","createdDate":"200812291657","description":"This nanoparticle is described in\r\nLiu Z, Winters M, Holodniy M, Dai H\r\nsiRNA delivery into human T cells and primary cells with carbon-nanotube transporters\r\nAngew Chem Int Ed Engl 46:2023-2027 (2007).\r\n\r\nSingle wall carbon nanotube functionalized with polymer coat and attached bioluminescent reporter","id":"10780718","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"STANFORD-ZLiuACIEE-2007-08","createdDate":"200812291703","description":"This nanoparticle is described in\r\nLiu Z, Winters M, Holodniy M, Dai H\r\nsiRNA delivery into human T cells and primary cells with carbon-nanotube transporters\r\nAngew Chem Int Ed Engl 46:2023-2027 (2007).\r\n\r\nSingle wall carbon nanotube functionalized with polymer coat and attached siRNA","id":"10780719","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"STANFORD-ZLiuACIEE-2007-09","createdDate":"200812291736","description":"This nanoparticle is described in\r\nLiu Z, Winters M, Holodniy M, Dai H\r\nsiRNA delivery into human T cells and primary cells with carbon-nanotube transporters\r\nAngew Chem Int Ed Engl 46:2023-2027 (2007).\r\n\r\nSingle wall carbon nanotube functionalized with polymer coat and attached siRNA","id":"10780720","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"STANFORD-ZLiuACIEE-2007-10","createdDate":"200812291742","description":"This nanoparticle is described in\r\nLiu Z, Winters M, Holodniy M, Dai H\r\nsiRNA delivery into human T cells and primary cells with carbon-nanotube transporters\r\nAngew Chem Int Ed Engl 46:2023-2027 (2007).\r\n\r\nLiposome","id":"10780721","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"STANFORD-ZLiuACIEE-2007-11","createdDate":"200812291746","description":"This nanoparticle is described in\r\nLiu Z, Winters M, Holodniy M, Dai H\r\nsiRNA delivery into human T cells and primary cells with carbon-nanotube transporters\r\nAngew Chem Int Ed Engl 46:2023-2027 (2007).\r\n\r\nLiposome with encapsulated siRNA","id":"10780722","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"STANFORD-ZLiuACIEE-2007-12","createdDate":"200812291802","description":"This nanoparticle is described in\r\nLiu Z, Winters M, Holodniy M, Dai H\r\nsiRNA delivery into human T cells and primary cells with carbon-nanotube transporters\r\nAngew Chem Int Ed Engl 46:2023-2027 (2007).\r\n\r\nLiposome with encapsulated siRNA","id":"10780723","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"STANFORD-ZLiuACIEE-2007-13","createdDate":"200812291819","description":"This nanoparticle is described in\r\nLiu Z, Winters M, Holodniy M, Dai H\r\nsiRNA delivery into human T cells and primary cells with carbon-nanotube transporters\r\nAngew Chem Int Ed Engl 46:2023-2027 (2007).\r\n\r\nLiposome with encapsulated siRNA","id":"10780724","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"STANFORD-ZLiuACIEE-2007-14","createdDate":"200812291823","description":"This nanoparticle is described in\r\nLiu Z, Winters M, Holodniy M, Dai H\r\nsiRNA delivery into human T cells and primary cells with carbon-nanotube transporters\r\nAngew Chem Int Ed Engl 46:2023-2027 (2007).\r\n\r\nLiposome with encapsulated siRNA","id":"10780725","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"STANFORD-ZLiuACIEE-2007-15","createdDate":"200812291827","description":"This nanoparticle is described in\r\nLiu Z, Winters M, Holodniy M, Dai H\r\nsiRNA delivery into human T cells and primary cells with carbon-nanotube transporters\r\nAngew Chem Int Ed Engl 46:2023-2027 (2007).\r\n\r\nLiposome with encapsulated siRNA","id":"10780726","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"STANFORD-ZLiuACIEE-2007-16","createdDate":"200812291831","description":"This nanoparticle is described in\r\nLiu Z, Winters M, Holodniy M, Dai H\r\nsiRNA delivery into human T cells and primary cells with carbon-nanotube transporters\r\nAngew Chem Int Ed Engl 46:2023-2027 (2007).\r\n\r\nLiposome with encapsulated siRNA","id":"10780727","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"UM-IMajorosBM2006-03","createdDate":"200902101852","description":"This nanoparticle is described in\r\nMajoros IJ, Myc A, Thomas T, Mehta CB, and Baker JR\r\nPAMAM Dendrimer-Based Multifunctional Conjugate for Cancer\r\nTherapy: Synthesis, Characterization, and Functionality\r\nBiomacromolecules 7:572-579 (2006).\r\n\r\nAcetylated PAMAM dendrimer and fluorescent agent conjugate","id":"10780759","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"UM-IMajorosBM2006-04","createdDate":"200902101854","description":"This nanoparticle is described in\r\nMajoros IJ, Myc A, Thomas T, Mehta CB, and Baker JR\r\nPAMAM Dendrimer-Based Multifunctional Conjugate for Cancer\r\nTherapy: Synthesis, Characterization, and Functionality\r\nBiomacromolecules 7:572-579 (2006).\r\n\r\nAcetylated PAMAM dendrimer, fluorescent, and targeting agents conjugate","id":"10780760","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"UM-IMajorosBM2006-05","createdDate":"200902101847","description":"This nanoparticle is described in\r\nMajoros IJ, Myc A, Thomas T, Mehta CB, and Baker JR\r\nPAMAM Dendrimer-Based Multifunctional Conjugate for Cancer\r\nTherapy: Synthesis, Characterization, and Functionality\r\nBiomacromolecules 7:572-579 (2006).\r\n\r\nGlycidylated PAMAM dendrimer, fluorescent, and targeting agents conjugate","id":"10780761","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"UM-IMajorosBM2006-06","createdDate":"200902101906","description":"This nanoparticle is described in\r\nMajoros IJ, Myc A, Thomas T, Mehta CB, and Baker JR\r\nPAMAM Dendrimer-Based Multifunctional Conjugate for Cancer\r\nTherapy: Synthesis, Characterization, and Functionality\r\nBiomacromolecules 7:572-579 (2006).\r\n\r\nGlycidylated PAMAM dendrimer, fluorescent, targeting, and therapeutic agents conjugate","id":"10780762","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"JST_AIST_FHU_TU_NEC_MU-MZhangPNAS2008-01","createdDate":"200905181302","description":"This nanoparticle is described in \r\nZhang M, Murakami T, Ajima K, Tsuchida K, Sandanayaka AS, Ito O, Iijima S, Yudasaka M.\r\nFabrication of ZnPc/protein nanohorns for double photodynamic and hyperthermic cancer phototherapy.\r\nProc Natl Acad Sci U S A 105:14773-8 (2008).\r\n\r\nSingle wall carbon nanohorn with open holes and attached protein","id":"12451855","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"JST_AIST_FHU_TU_NEC_MU-MZhangPNAS2008-03","createdDate":"200905181354","description":"This nanoparticle is described in \r\nZhang M, Murakami T, Ajima K, Tsuchida K, Sandanayaka AS, Ito O, Iijima S, Yudasaka M.\r\nFabrication of ZnPc/protein nanohorns for double photodynamic and hyperthermic cancer phototherapy.\r\nProc Natl Acad Sci U S A 105:14773-8 (2008).\r\n\r\nSingle wall carbon nanohorn with open holes, attached protein and fluorophore conjugate","id":"12451857","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"PURDUE-CWAngACIEE-03","createdDate":"200906122035","description":"This nanoparticle is described in\r\nWang C, Chen J, Talavage T, Irudayaraj J.\r\nGold nanorod/Fe3O4 nanoparticle \"nano-pearl-necklaces\" for simultaneous targeting, dual-mode imaging,\r\nand photothermal ablation of cancer cells.\r\nAngew Chem Int Ed Engl 48:2759-2763 (2009).      \r\n\r\nAmine modified gold nanorod","id":"13041681","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"PURDUE-CWAngACIEE-04","createdDate":"200906122049","description":"This nanoparticle is described in\r\nWang C, Chen J, Talavage T, Irudayaraj J.\r\nGold nanorod/Fe3O4 nanoparticle \"nano-pearl-necklaces\" for simultaneous targeting, dual-mode imaging,\r\nand photothermal ablation of cancer cells.\r\nAngew Chem Int Ed Engl 48:2759-2763 (2009).      \r\n\r\nAmine modified gold nanorod with polymer coat","id":"13041682","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"NEU-ADesaiJPS2008-01","createdDate":"200907061526","description":"This nanoparticle is described in \r\nDesai A, Vyas T, Amiji M\r\nCytotoxicity and apoptosis enhancement in brain tumor cells upon\r\ncoadministration of paclitaxel and ceramide in nanoemulsion formulations.\r\nJ Pharm Sci  2008 Jul;97(7):2745-56.\r\n\r\nPine nut oil emulsion nanoparticle","id":"13041711","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"NEU-ADesaiJPS2008-02","createdDate":"200907061741","description":"This nanoparticle is described in \r\nDesai A, Vyas T, Amiji M\r\nCytotoxicity and apoptosis enhancement in brain tumor cells upon\r\ncoadministration of paclitaxel and ceramide in nanoemulsion formulations.\r\nJ Pharm Sci  2008 Jul;97(7):2745-56.\r\n\r\nPine nut oil emulsion nanoparticle loaded with drug","id":"13041712","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"NEU-ADesaiJPS2008-03","createdDate":"200907061814","description":"This nanoparticle is described in \r\nDesai A, Vyas T, Amiji M\r\nCytotoxicity and apoptosis enhancement in brain tumor cells upon\r\ncoadministration of paclitaxel and ceramide in nanoemulsion formulations.\r\nJ Pharm Sci  2008 Jul;97(7):2745-56.\r\n\r\nPine nut oil emulsion nanoparticle loaded with drug","id":"13041713","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"NEU-ADesaiJPS2008-04","createdDate":"200907061825","description":"This nanoparticle is described in \r\nDesai A, Vyas T, Amiji M\r\nCytotoxicity and apoptosis enhancement in brain tumor cells upon\r\ncoadministration of paclitaxel and ceramide in nanoemulsion formulations.\r\nJ Pharm Sci  2008 Jul;97(7):2745-56.\r\n\r\nPine nut oil emulsion nanoparticle loaded with sphingolipid ","id":"13041714","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"NEU-ADesaiJPS2008-05","createdDate":"200907061840","description":"This nanoparticle is described in \r\nDesai A, Vyas T, Amiji M\r\nCytotoxicity and apoptosis enhancement in brain tumor cells upon\r\ncoadministration of paclitaxel and ceramide in nanoemulsion formulations.\r\nJ Pharm Sci  2008 Jul;97(7):2745-56.\r\n\r\nPine nut oil emulsion nanoparticle loaded with with sphingolipid","id":"13041715","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"NEU-ADesaiJPS2008-06","createdDate":"200907061902","description":"This nanoparticle is described in \r\nDesai A, Vyas T, Amiji M\r\nCytotoxicity and apoptosis enhancement in brain tumor cells upon\r\ncoadministration of paclitaxel and ceramide in nanoemulsion formulations.\r\nJ Pharm Sci  2008 Jul;97(7):2745-56.\r\n\r\nPine nut oil emulsion nanoparticle loaded with drug and sphingolipid","id":"13041716","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"NEU-ADesaiJPS2008-07","createdDate":"200907061916","description":"This nanoparticle is described in \r\nDesai A, Vyas T, Amiji M\r\nCytotoxicity and apoptosis enhancement in brain tumor cells upon\r\ncoadministration of paclitaxel and ceramide in nanoemulsion formulations.\r\nJ Pharm Sci  2008 Jul;97(7):2745-56.\r\n\r\nPine nut oil emulsion nanoparticle loaded with drug and sphingolipid","id":"13041717","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"NEU-ADesaiJPS2008-08","createdDate":"200907061930","description":"This nanoparticle is described in \r\nDesai A, Vyas T, Amiji M\r\nCytotoxicity and apoptosis enhancement in brain tumor cells upon\r\ncoadministration of paclitaxel and ceramide in nanoemulsion formulations.\r\nJ Pharm Sci  2008 Jul;97(7):2745-56.\r\n\r\nPine nut oil emulsion nanoparticle loaded with drug and sphingolipid ","id":"13041718","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"NEU-ADesaiJPS2008-09","createdDate":"200907062055","description":"This nanoparticle is described in \r\nDesai A, Vyas T, Amiji M\r\nCytotoxicity and apoptosis enhancement in brain tumor cells upon\r\ncoadministration of paclitaxel and ceramide in nanoemulsion formulations.\r\nJ Pharm Sci  2008 Jul;97(7):2745-56.\r\n\r\nPine nut oil emulsion nanoparticle loaded with drug and sphingolipid","id":"13041719","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"NEU-ADesaiJPS2008-10","createdDate":"200907061958","description":"This nanoparticle is described in \r\nDesai A, Vyas T, Amiji M\r\nCytotoxicity and apoptosis enhancement in brain tumor cells upon\r\ncoadministration of paclitaxel and ceramide in nanoemulsion formulations.\r\nJ Pharm Sci  2008 Jul;97(7):2745-56.\r\n\r\nPine nut oil emulsion nanoparticle loaded with drug having attached fluorone dye ","id":"13041720","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"NEU-ADesaiJPS2008-11","createdDate":"200907062105","description":"This nanoparticle is described in \r\nDesai A, Vyas T, Amiji M\r\nCytotoxicity and apoptosis enhancement in brain tumor cells upon\r\ncoadministration of paclitaxel and ceramide in nanoemulsion formulations.\r\nJ Pharm Sci  2008 Jul;97(7):2745-56.\r\n\r\nPine nut oil emulsion nanoparticle loaded with fluorescent sphingolipid","id":"13041721","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"WUSTL-ANystromCC2008-01","createdDate":"200907211752","description":"This nanoparticle is described in\r\nNystrom AM, Xu Z, Xu J, Taylor S, Nittis T, Stewart SA, Leonard J, Wooley KL.\r\nSCKs as nanoparticle carriers of doxorubicin: investigation of core composition on the loading, release and cytotoxicity profiles\r\nChem Commun 14:3579-3581 (2008).\r\n\r\nShell crosslinked block copolymer","id":"13041724","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"WUSTL-ANystromCC2008-02","createdDate":"200907211756","description":"This nanoparticle is described in\r\nNystrom AM, Xu Z, Xu J, Taylor S, Nittis T, Stewart SA, Leonard J, Wooley KL.\r\nSCKs as nanoparticle carriers of doxorubicin: investigation of core composition on the loading, release and cytotoxicity profiles\r\nChem Commun 14:3579-3581 (2008).\r\n\r\nShell crosslinked block copolymer loaded with drug","id":"13041725","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"WUSTL-ANystromCC2008-03","createdDate":"200907211759","description":"This nanoparticle is described in\r\nNystrom AM, Xu Z, Xu J, Taylor S, Nittis T, Stewart SA, Leonard J, Wooley KL.\r\nSCKs as nanoparticle carriers of doxorubicin: investigation of core composition on the loading, release and cytotoxicity profiles\r\nChem Commun 14:3579-3581 (2008).\r\n\r\nShell crosslinked block copolymer loaded with drug","id":"13041726","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"WUSTL-ANystromCC2008-04","createdDate":"200907211803","description":"This nanoparticle is described in\r\nNystrom AM, Xu Z, Xu J, Taylor S, Nittis T, Stewart SA, Leonard J, Wooley KL.\r\nSCKs as nanoparticle carriers of doxorubicin: investigation of core composition on the loading, release and cytotoxicity profiles\r\nChem Commun 14:3579-3581 (2008).\r\n\r\nShell crosslinked block copolymer","id":"13041727","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"WUSTL-ANystromCC2008-05","createdDate":"200907211807","description":"This nanoparticle is described in\r\nNystrom AM, Xu Z, Xu J, Taylor S, Nittis T, Stewart SA, Leonard J, Wooley KL.\r\nSCKs as nanoparticle carriers of doxorubicin: investigation of core composition on the loading, release and cytotoxicity profiles\r\nChem Commun 14:3579-3581 (2008).\r\n\r\nShell crosslinked block copolymer loaded with drug","id":"13041728","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"WUSTL-ANystromCC2008-06","createdDate":"200907211812","description":"This nanoparticle is described in\r\nNystrom AM, Xu Z, Xu J, Taylor S, Nittis T, Stewart SA, Leonard J, Wooley KL.\r\nSCKs as nanoparticle carriers of doxorubicin: investigation of core composition on the loading, release and cytotoxicity profiles\r\nChem Commun 14:3579-3581 (2008).\r\n\r\nShell crosslinked block copolymer loaded with drug","id":"13041729","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"NIOSH-VWalkerTAP2009-01","createdDate":"200910072021","description":"This nanoparticle is described in\r\nWalker VG, Li Z, Hulderman T, Schwegler-Berry D, Kashon ML, Simeonova PP.\r\nPotential in vitro effects of carbon nanotubes on human aortic endothelial cells.\r\nToxicol Appl Pharmacol 236:319-28 (2009).\r\n\r\nCarbon Black particle","id":"13041747","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"CLM_UHA_CDS_INSERM-TDaouLGMR2009-01","createdDate":"200910141731","description":"This nanoparticle is described in \r\nDaou TJ, Li L, Reiss P, Josserand V, Texier I.\r\nEffect of poly(ethylene glycol) length on the in vivo behavior of coated quantum dots.\r\nLangmuir 25:3040-3044 (2009).\r\n\r\nAmine functionalized PEG coated red quantum dot\r\nEmission quantum yield  100%","id":"13631488","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"UTHSCH_UMG_MDACC_RU_UTA-PDecuzziJCR2010-01","createdDate":"201206271551","description":"This microparticle is described in \r\nDecuzzi P, Godin B, Tanaka T,  Lee S.-Y, Chiappini C, Liu X, Ferrari M.\r\nSize and shape effects in the biodistribution of intravascularly injected particles.\r\nJ Control Release 141:320-327 (2010).\r\n\r\nSpherical silica particle","id":"33161216","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"UTHSCH_UMG_MDACC_RU_UTA-PDecuzziJCR2010-03","createdDate":"201206271551","description":"This microparticle is described in \r\nDecuzzi P, Godin B, Tanaka T,  Lee S.-Y, Chiappini C, Liu X, Ferrari M.\r\nSize and shape effects in the biodistribution of intravascularly injected particles.\r\nJ Control Release 141:320-327 (2010).\r\n\r\nSpherical silica particle","id":"33161217","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"UTHSCH_UMG_MDACC_RU_UTA-PDecuzziJCR2010-02","createdDate":"201206271551","description":"This microparticle is described in \r\nDecuzzi P, Godin B, Tanaka T,  Lee S.-Y, Chiappini C, Liu X, Ferrari M.\r\nSize and shape effects in the biodistribution of intravascularly injected particles.\r\nJ Control Release 141:320-327 (2010).\r\n\r\nSpherical silica particle","id":"33161218","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"UTHSCH_UMG_MDACC_RU_UTA-PDecuzziJCR2010-05","createdDate":"201206271551","description":"This microparticle is described in \r\nDecuzzi P, Godin B, Tanaka T,  Lee S.-Y, Chiappini C, Liu X, Ferrari M.\r\nSize and shape effects in the biodistribution of intravascularly injected particles.\r\nJ Control Release 141:320-327 (2010).\r\n\r\nSpherical silica particle","id":"33161221","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"UTHSCH_UMG_MDACC_RU_UTA-PDecuzziJCR2010-06","createdDate":"201206271551","description":"This microparticle is described in \r\nDecuzzi P, Godin B, Tanaka T,  Lee S.-Y, Chiappini C, Liu X, Ferrari M.\r\nSize and shape effects in the biodistribution of intravascularly injected particles.\r\nJ Control Release 141:320-327 (2010).\r\n\r\nSpherical silica particle","id":"33161222","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"sample","name":"UTHSCH_UMG_MDACC_RU_UTA-PDecuzziJCR2010-08","createdDate":"201206290022","description":"This microparticle is described in \r\nDecuzzi P, Godin B, Tanaka T,  Lee S.-Y, Chiappini C, Liu X, Ferrari M.\r\nSize and shape effects in the biodistribution of intravascularly injected particles.\r\nJ Control Release 141:320-327 (2010).\r\n\r\nDiscoidal non-porous silicone particle","id":"33161224","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"publication","name":"A multimodal targeting nanoparticle for selectively labeling T cells","createdDate":"201004291856","description":null,"id":"26345832","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"publication","name":"A Multimodal Targeting Nanoparticle for Selectively Labeling T Cells","createdDate":"201004291858","description":null,"id":"26345890","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"publication","name":"Hybrid magnetic nanostructures (MNS) for magnetic resonance imaging applications.","createdDate":"201311012139","description":"The development of MRI contrast agents has experienced its version of the gilded age over the past decade, thanks largely to the rapid advances in nanotechnology. In addition to progress in single mode contrast agents, which ushered in unprecedented R(1) or R(2) sensitivities, there has also been a boon in the development of agents covering more than one mode of detection. These include T(1)-PET, T(2)-PET T(1)-optical, T(2)-optical, T(1)-T(2) agents and many others. In this review, we describe four areas which we feel have experienced particular growth due to nanotechnology, specifically T(2) magnetic nanostructure development, T(1)/T(2)-optical dual mode agents, and most recently the T(1)-T(2) hybrid imaging systems. In each of these systems, we describe applications including in vitro, in vivo usage and assay development. In all, while the benefits and drawbacks of most MRI contrast agents depend on the application at hand, the recent development in multimodal nanohybrids may curtail the shortcomings of single mode agents in diagnostic and clinical settings by synergistically incorporating functionality. It is hoped that as nanotechnology advances over the next decade, it will produce agents with increased diagnostics and assay relevant capabilities in streamlined packages that can meaningfully improve patient care and prognostics. In this review article, we focus on T(2) materials, its surface functionalization and coupling with optical and/or T(1) agents.","id":"39879268","pubmedId":"21851844","fileId":null,"fileTitle":null,"editable":false},{"type":"publication","name":"miRNA profiling of naïve, effector and memory CD8 T cells.","createdDate":"201004291902","description":"microRNAs have recently emerged as master regulators of gene expression during development and cell differentiation. Although profound changes in gene expression also occur during antigen-induced T cell differentiation, the role of miRNAs in the process is not known. We compared the miRNA expression profiles between antigen-specific naïve, effector and memory CD8+ T cells using 3 different methods--small RNA cloning, miRNA microarray analysis and real-time PCR. Although many miRNAs were expressed in all the T cell subsets, the frequency of 7 miRNAs (miR-16, miR-21, miR-142-3p, miR-142-5p, miR-150, miR-15b and let-7f) alone accounted for approximately 60% of all miRNAs, and their expression was several fold higher than the other expressed miRNAs. Global downregulation of miRNAs (including 6/7 dominantly expressed miRNAs) was observed in effector T cells compared to naïve cells and the miRNA expression levels tended to come back up in memory T cells. However, a few miRNAs, notably miR-21 were higher in effector and memory T cells compared to naïve T cells. These results suggest that concomitant with profound changes in gene expression, miRNA profile also changes dynamically during T cell differentiation. Sequence analysis of the cloned mature miRNAs revealed an extensive degree of end polymorphism. While 3'end polymorphisms dominated, heterogeneity at both ends, resembling drosha/dicer processing shift was also seen in miR-142, suggesting a possible novel mechanism to generate new miRNA and/or to diversify miRNA target selection. Overall, our results suggest that dynamic changes in the expression of miRNAs may be important for the regulation of gene expression during antigen-induced T cell differentiation. Our study also suggests possible novel mechanisms for miRNA biogenesis and function.","id":"26346022","pubmedId":"17925868","fileId":null,"fileTitle":null,"editable":false},{"type":"publication","name":"In vivo quantification of T1, T2, and apparent diffusion coefficient in the mouse retina at 11.74T.","createdDate":"201004291858","description":"MRI has recently been used for noninvasive examination of retinal structure and function in rats and cats. However, the advantages of quantitative high-resolution MRI of retina from mice have not yet been explored. In the present study, T(1) and T(2) relaxation time constants and the directional apparent diffusion coefficient (ADC) in the retina of C57/BL6 mice were measured. Three MR-detected retina layers and a MR-detected choroid layer were observed on both T(1)- and T(2)-weighted images at an image resolution of 47 x 47 x 400 microm(3). The significantly higher ADC parallel to than that perpendicular to the optic nerve in the MR-detected outer retina layer at the central retina reflects the known cellular organization of the photoreceptor cells. This study establishes, for the first time, normative metrics of T(1), T(2), and ADC of the mouse retina. These MR parameters are expected to be useful in future evaluation of developmental and pathological alterations of retinal cell layers in mice.","id":"26345882","pubmedId":"18383302","fileId":null,"fileTitle":null,"editable":false},{"type":"publication","name":"New directions in cellular therapy of cancer: a summary of the summit on cellular therapy for cancer.","createdDate":"201311012037","description":"A summit on cellular therapy for cancer discussed and presented advances related to the use of adoptive cellular therapy for melanoma and other cancers. The summit revealed that this field is advancing rapidly. Conventional cellular therapies, such as tumor infiltrating lymphocytes (TIL), are becoming more effective and more available. Gene therapy is becoming an important tool in adoptive cell therapy. Lymphocytes are being engineered to express high affinity T cell receptors (TCRs), chimeric antibody-T cell receptors (CARs) and cytokines. T cell subsets with more naïve and stem cell-like characteristics have been shown in pre-clinical models to be more effective than unselected populations and it is now possible to reprogram T cells and to produce T cells with stem cell characteristics. In the future, combinations of adoptive transfer of T cells and specific vaccination against the cognate antigen can be envisaged to further enhance the effectiveness of these therapies.","id":"39878782","pubmedId":"22420641","fileId":null,"fileTitle":null,"editable":false},{"type":"publication","name":"Modular nucleic acid assembled p/MHC microarrays for multiplexed sorting of antigen-specific T cells.","createdDate":"201004291848","description":"The human immune system consists of a large number of T cells capable of recognizing and responding to antigens derived from various sources. The development of peptide-major histocompatibility (p/MHC) tetrameric complexes has enabled the direct detection of these antigen-specific T cells. With the goal of increasing throughput and multiplexing of T cell detection, protein microarrays spotted with defined p/MHC complexes have been reported, but studies have been limited due to the inherent instability and reproducibility of arrays produced via conventional spotted methods. Herein, we report on a platform for the detection of antigen-specific T cells on glass substrates that offers significant advantages over existing surface-bound schemes. In this approach, called \"Nucleic Acid Cell Sorting (NACS)\", single-stranded DNA oligomers conjugated site-specifically to p/MHC tetramers are employed to immobilize p/MHC tetramers via hybridization to a complementary-printed substrate. Fully assembled p/MHC arrays are used to detect and enumerate T cells captured from cellular suspensions, including primary human T cells collected from cancer patients. NACS arrays outperform conventional spotted arrays assessed in key criteria such as repeatability and homogeneity. The versatility of employing DNA sequences for cell sorting is exploited to enable the programmed, selective release of target populations of immobilized T cells with restriction endonucleases for downstream analysis. Because of the performance, facile and modular assembly of p/MHC tetramer arrays, NACS holds promise as a versatile platform for multiplexed T cell detection.","id":"26345502","pubmedId":"19552409","fileId":null,"fileTitle":null,"editable":false},{"type":"publication","name":"A folate receptor-targeting nanoparticle minimizes drug resistance in a human cancer model.","createdDate":"201311012109","description":"Resistance to chemotherapy is a major obstacle in cancer therapy. The main purpose of this study is to evaluate the potential of a folate receptor-targeting nanoparticle to overcome/minimize drug resistance and to explore the underlying mechanisms. This is accomplished with enhanced cellular accumulation and retention of paclitaxel (one of the most effective anticancer drugs in use today and a well-known P-glycoprotein (P-gp) substrate) in a P-gp-overexpressing cancer model. The folate receptor-targeted nanoparticle, HFT-T, consists of a heparin-folate-paclitaxel (HFT) backbone with an additional paclitaxel (T) loaded in its hydrophobic core. In vitro analyses demonstrated that the HFT-T nanoparticle was superior to free paclitaxel or nontargeted nanoparticle (HT-T) in inhibiting proliferation of P-gp-overexpressing cancer cells (KB-8-5), partially due to its enhanced uptake and prolonged intracellular retention. In a subcutaneous KB-8-5 xenograft model, HFT-T administration enhanced the specific delivery of paclitaxel into tumor tissues and remarkably prolonged retention within tumor tissues. Importantly, HFT-T treatment markedly retarded tumor growth in a xenograft model of resistant human squamous cancer. Immunohistochemical analysis further indicated that increased in vivo efficacy of HFT-T nanoparticles was associated with a higher degree of microtubule stabilization, mitotic arrest, antiangiogenic activity, and inhibition of cell proliferation. These findings suggest that when the paclitaxel was delivered as an HFT-T nanoparticle, the drug is better retained within the P-gp-overexpressing cells than the free form of paclitaxel. These results indicated that the targeted HFT-T nanoparticle may be promising in minimizing P-gp related drug resistance and enhancing therapeutic efficacy compared with the free form of paclitaxel.","id":"39879031","pubmedId":"21728341","fileId":null,"fileTitle":null,"editable":false},{"type":"publication","name":"Suppression of leukemia development caused by PTEN loss.","createdDate":"201311012134","description":"Multiple genetic or molecular alterations are known to be associated with cancer stem cell formation and cancer development. Targeting such alterations, therefore, may lead to cancer prevention. By crossing our previously established phosphatase and tensin homolog (Pten)-null acute T-lymphoblastic leukemia (T-ALL) model onto the recombination-activating gene 1(-/-) background, we show that the lack of variable, diversity and joining [V(D)J] recombination completely abolishes the Tcr?/?-c-myc translocation and T-ALL development, regardless of ?-catenin activation. We identify mammalian target of rapamycin (mTOR) as a regulator of ?-selection. Rapamycin, an mTOR-specific inhibitor, alters nutrient sensing and blocks T-cell differentiation from CD4(-)CD8(-) to CD4(+)CD8(+), the stage where the Tcr?/?-c-myc translocation occurs. Long-term rapamycin treatment of preleukemic Pten-null mice prevents Tcr?/?-c-myc translocation and leukemia stem cell (LSC) formation, and it halts T-ALL development. However, rapamycin alone fails to inhibit mTOR signaling in the c-Kit(mid)CD3(+)Lin(-) population enriched for LSCs and eliminate these cells. Our results support the idea that preventing LSC formation and selectively targeting LSCs are promising approaches for antileukemia therapies.","id":"39879226","pubmedId":"21212363","fileId":null,"fileTitle":null,"editable":false},{"type":"publication","name":"Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy","createdDate":"201004291853","description":"Magnetic iron oxide (IO) nanoparticles with a long blood retention time, biodegradability and low toxicity have emerged as one of the primary nanomaterials for biomedical applications in vitro and in vivo. IO nanoparticles have a large surface area and can be engineered to provide a large number of functional groups for cross-linking to tumor-targeting ligands such as monoclonal antibodies, peptides, or small molecules for diagnostic imaging or delivery of therapeutic agents. IO nanoparticles possess unique paramagnetic properties, which generate significant susceptibility effects resulting in strong T-2 and T-2* contrast, as well as T-1 effects at very low concentrations for magnetic resonance imaging (MRI), which is widely used for clinical oncology imaging. We review recent advances in the development of targeted IO nanoparticles for tumor imaging and therapy.","id":"26345699","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"publication","name":"Synthesis and characterization of ruthenium and rhenium nucleosides.","createdDate":"201004291901","description":"We report the synthesis and characterization of new ruthenium and rhenium nucleosides [Ru(tolyl-acac)2(IMPy)-T] (tolyl-acac=di(p-methylbenzonatemethane), IMPy=2'-iminomethylpyridine, T=thymidine) (5) and [Re(CO)3(IMPy)-T]Cl (9), respectively. Structural analysis of 9 shows that the incorporation of this metal complex causes minimal perturbation to the sugar backbone and the nucleobase. Eletrochemical (5, E1/2=0.265 V vs NHE; 9, E1/2=1.67 V vs NHE), absorption (5, lambdamax=600, 486 nm; 9, lambdamax=388 nm), and emission (9, lambdamax=770 nm, pi=17 ns) data indicate that 5 and 9 are suitable probes for DNA-mediated ground-state electron-transfer studies. The separation and characterization of diastereoisomers of 5 and bipyridyl-based ruthenium nucleoside [Ru(bpy)2(IMPy)-T]2+ (7) are reported.","id":"26346006","pubmedId":"17948987","fileId":null,"fileTitle":null,"editable":false},{"type":"publication","name":"Impact of diffusion barriers to small cytotoxic molecules on the efficacy of immunotherapy in breast cancer.","createdDate":"201311012026","description":"Molecular-focused cancer therapies, e.g., molecularly targeted therapy and immunotherapy, so far demonstrate only limited efficacy in cancer patients. We hypothesize that underestimating the role of biophysical factors that impact the delivery of drugs or cytotoxic cells to the target sites (for associated preferential cytotoxicity or cell signaling modulation) may be responsible for the poor clinical outcome. Therefore, instead of focusing exclusively on the investigation of molecular mechanisms in cancer cells, convection-diffusion of cytotoxic molecules and migration of cancer-killing cells within tumor tissue should be taken into account to improve therapeutic effectiveness. To test this hypothesis, we have developed a mathematical model of the interstitial diffusion and uptake of small cytotoxic molecules secreted by T-cells, which is capable of predicting breast cancer growth inhibition as measured both in vitro and in vivo. Our analysis shows that diffusion barriers of cytotoxic molecules conspire with ?? T-cell scarcity in tissue to limit the inhibitory effects of ?? T-cells on cancer cells. This may increase the necessary ratios of ?? T-cells to cancer cells within tissue to unrealistic values for having an intended therapeutic effect, and decrease the effectiveness of the immunotherapeutic treatment.","id":"39878694","pubmedId":"23620747","fileId":null,"fileTitle":null,"editable":false},{"type":"publication","name":"Luminescent silica nanobeads: characterization and evaluation as efficient cytoplasmatic transporters for T-lymphocytes.","createdDate":"201004291905","description":"We report the fabrication and characterization of neutravidin-conjugated silica nanobeads doped with a ruthenium-complex luminophore and functionalized with antihuman CD3, antihuman CD28, and an acid-sensitive polymer. We observed that the nanobeads were readily delivered into Jurkat T leukemia cells by endocytosis, transported into lysosomes and subsequently into the cytoplasm as revealed by pH-sensitive luminescence. Since signs of cytotoxicity were not observed, the reported nanobeads could be an excellent and nontoxic building block for efficient intracellular transporters.","id":"26346120","pubmedId":"17542582","fileId":null,"fileTitle":null,"editable":false},{"type":"publication","name":"Multi-genetic events collaboratively contribute to Pten-null leukaemia stem-cell formation","createdDate":"201004291857","description":"Cancer stem cells, which share many common properties and regulatory machineries with normal stem cells, have recently been proposed to be responsible for tumorigenesis and to contribute to cancer resistance(1). The main challenges in cancer biology are to identify cancer stem cells and to define the molecular events required for transforming normal cells to cancer stem cells. Here we show that Pten deletion in mouse haematopoietic stem cells leads to a myeloproliferative disorder, followed by acute T-lymphoblastic leukaemia (T-ALL). Self- renewable leukaemia stem cells (LSCs) are enriched in the c-Kit(mid)CD3(+)Lin(-) compartment, where unphosphorylated beta-catenin is significantly increased. Conditional ablation of one allele of the beta-catenin gene substantially decreases the incidence and delays the occurrence of T-ALL caused by Pten loss, indicating that activation of the beta-catenin pathway may contribute to the formation or expansion of the LSC population. Moreover, a recurring chromosomal translocation, T(14;15), results in aberrant overexpression of the c-myc oncogene in c-Kit mid CD3(+)Lin(-) LSCs and CD3(+) leukaemic blasts, recapitulating a subset of human T-ALL. No alterations in Notch1 signalling are detected in this model, suggesting that Pten inactivation and c-myc overexpression may substitute functionally for Notch1 abnormalities(2,3), leading to T-ALL development. Our study indicates that multiple genetic or molecular alterations contribute cooperatively to LSC transformation.","id":"26345858","pubmedId":null,"fileId":null,"fileTitle":null,"editable":false},{"type":"publication","name":"Differential role of ICAM ligands in determination of human memory T cell differentiation.","createdDate":"201004291909","description":"BACKGROUND: Leukocyte Function Antigen-1 (LFA-1) is a primary adhesion molecule that plays important roles in T cell activation, leukocyte recirculation, and trans-endothelial migration. By applying a multivariate intracellular phospho-proteomic analysis, we demonstrate that LFA-1 differentially activates signaling molecules. RESULTS: Signal intensity was dependent on both ICAM ligand and LFA-1 concentration. In the presence of CD3 and CD28 stimulation, ICAM-2 and ICAM-3 decreased TGFbeta1 production more than ICAM-1. In long-term differentiation experiments, stimulation with ICAM-3, CD3, and CD28 generated IFNgamma producing CD4+CD45RO+CD62L-CD11aBrightCD27- cells that had increased expression of intracellular BCL2, displayed distinct chemokine receptor profiles, and exhibited distinct migratory characteristics. Only CD3/CD28 with ICAM-3 generated CD4+CD45RO+CD62L-CD11aBrightCD27- cells that were functionally responsive to chemotaxis and exhibited higher frequencies of cells that signaled to JNK and ERK1/2 upon stimulation with MIP3alpha. Furthermore, these reports identify that the LFA-1 receptor, when presented with multiple ligands, can result in distinct T cell differentiation states and suggest that the combinatorial integration of ICAM ligand interactions with LFA-1 have functional consequences for T cell biology. CONCLUSION: Thus, the ICAM ligands, differentially modulate LFA-1 signaling in T cells and potentiate the development of memory human T cells in vitro. These findings are of importance in a mechanistic understanding of memory cell differentiation and ex vivo generation of memory cell subsets for therapeutic applications.","id":"26346228","pubmedId":"17233909","fileId":null,"fileTitle":null,"editable":false},{"type":"publication","name":"Multi-reservoir device for detecting a soluble cancer biomarker.","createdDate":"201004291902","description":"By combining the sensing capabilities of nanoscale magnetic relaxation switches (MRS) within multi-reservoir structures, a potentially powerful implantable multiplexed sensor has been developed. MRS are magnetic nanoparticles that decrease the transverse relaxation time (T(2)) of water in the presence of an analyte. The switches encased in polydimethylsiloxane (PDMS) devices with polycarbonate membranes (10 nm pores) have demonstrated in vitro sensing of the beta subunit of human chorionic gonadotrophin (hCG-beta), which is elevated in testicular and ovarian cancer. Devices showed transverse relaxation time (T(2)) shortening by magnetic resonance imaging (MRI) when incubated in analyte solutions of 0.5 to 5 microg hCG-beta mL(-1). The decrease in T(2) was between 9% and 27% (compared to control devices) after approximately 28 h. This prototype device is an important first step in developing an implantable sensor for detecting soluble cancer biomarkers in vivo.","id":"26346036","pubmedId":"17896012","fileId":null,"fileTitle":null,"editable":false},{"type":"publication","name":"In vivo imaging of T cell delivery to tumors after adoptive transfer therapy.","createdDate":"201004291904","description":"Adoptive transfer therapy of in vitro-expanded tumor-specific cytolytic T lymphocytes (CTLs) can mediate objective cancer regression in patients. Yet, technical limitations hamper precise monitoring of posttherapy T cell responses. Here we show in a mouse model that fused single photon emission computed tomography and x-ray computed tomography allows quantitative whole-body imaging of (111)In-oxine-labeled CTLs at tumor sites. Assessment of CTL localization is rapid, noninvasive, three-dimensional, and can be repeated for longitudinal analyses. We compared the effects of lymphodepletion before adoptive transfer on CTL recruitment and report that combined treatment increased intratumoral delivery of CTLs and improved antitumor efficacy. Because (111)In-oxine is a Food and Drug Administration-approved clinical agent, and human SPECT-CT systems are available, this approach should be clinically translatable, insofar as it may assess the efficacy of immunization procedures in individual patients and lead to development of more effective therapies.","id":"26346092","pubmedId":"17640914","fileId":null,"fileTitle":null,"editable":false},{"type":"publication","name":"Properties of an entropy-based signal receiver with an application to ultrasonic molecular imaging.","createdDate":"201004291905","description":"Qualitative and quantitative properties of the finite part, H(f), of the Shannon entropy of a continuous waveform f(t) in the continuum limit are derived in order to illuminate its use for waveform characterization. Simple upper and lower bounds on H(f), based on features of f(t), are defined. Quantitative criteria for a priori estimation of the average-case variation of H(f) and log E(f), where E(f) is the signal energy of f(t) are also derived. These provide relative sensitivity estimates that could be used to prospectively choose optimal imaging strategies in real-time ultrasonic imaging machines, where system bandwidth is often pushed to its limits. To demonstrate the utility of these sensitivity relations for this application, a study designed to assess the feasibility of identification of angiogenic neovasculature targeted with perfluorocarbon nanoparticles that specifically bind to alpha(v)beta3-integrin expression in tumors was performed. The outcome of this study agrees with the prospective sensitivity estimates that were used for the two receivers. Moreover, these data demonstrate the ability of entropy-based signal receivers when used in conjunction with targeted nanoparticles to elucidate the presence of alpha(v)beta3 integrins in primordial neovasculature, particularly in acoustically unfavorable environments.","id":"26346118","pubmedId":"17552706","fileId":null,"fileTitle":null,"editable":false},{"type":"publication","name":"A clinical microchip for evaluation of single immune cells reveals high functional heterogeneity in phenotypically similar T cells.","createdDate":"201311012125","description":"Cellular immunity has an inherent high level of functional heterogeneity. Capturing the full spectrum of these functions requires analysis of large numbers of effector molecules from single cells. We report a microfluidic platform designed for highly multiplexed (more than ten proteins), reliable, sample-efficient (?1 × 10(4) cells) and quantitative measurements of secreted proteins from single cells. We validated the platform by assessment of multiple inflammatory cytokines from lipopolysaccharide (LPS)-stimulated human macrophages and comparison to standard immunotechnologies. We applied the platform toward the ex vivo quantification of T cell polyfunctional diversity via the simultaneous measurement of a dozen effector molecules secreted from tumor antigen-specific cytotoxic T lymphocytes (CTLs) that were actively responding to tumor and compared against a cohort of healthy donor controls. We observed profound, yet focused, functional heterogeneity in active tumor antigen-specific CTLs, with the major functional phenotypes quantitatively identified. The platform represents a new and informative tool for immune monitoring and clinical assessment.","id":"39879153","pubmedId":"21602800","fileId":null,"fileTitle":null,"editable":false},{"type":"publication","name":"Immune-mediated regression of established B16F10 melanoma by intratumoral injection of attenuated Toxoplasma gondii protects against rechallenge.","createdDate":"201311012027","description":"Immune recognition of tumors can limit cancer development, but antitumor immune responses are often blocked by tumor-mediated immunosuppression. Because microbes or microbial constituents are powerful adjuvants to stimulate immune responses, we evaluated whether intratumoral administration of a highly immunogenic but attenuated parasite could induce rejection of an established poorly immunogenic tumor. We treated intradermal B16F10 murine melanoma by intratumoral injection of an attenuated strain of Toxoplasma gondii (cps) that cannot replicate in vivo and therefore is not infective. The cps treatment stimulated a strong CD8(+) T cell-mediated antitumor immune response in vivo that regressed established primary melanoma. The cps monotherapy rapidly modified the tumor microenvironment, halting tumor growth, and subsequently, as tumor-reactive T cells expanded, the tumors disappeared and rarely returned. The treatment required live cps that could invade cells and also required CD8(+) T cells and NK cells, but did not require CD4(+) T cells. Furthermore, we demonstrate that IL-12, IFN-?, and the CXCR3-stimulating cytokines are required for full treatment efficacy. The treatment developed systemic antitumor immune activity as well as antitumor immune memory and therefore might have an impact against human metastatic disease. The approach is not specific for either B16F10 or melanoma. Direct intratumoral injection of cps has efficacy against an inducible genetic melanoma model and transplantable lung and ovarian tumors, demonstrating potential for broad clinical use. The combination of efficacy, systemic antitumor immune response, and complete attenuation with no observed host toxicity demonstrates the potential value of this novel cancer therapy.","id":"39878698","pubmedId":"23225891","fileId":null,"fileTitle":null,"editable":false},{"type":"publication","name":"T?-weighted ultrashort echo time method for positive contrast imaging of magnetic nanoparticles and cancer cells bound with the targeted nanoparticles.","createdDate":"201311012104","description":"UTE imaging allows for imaging of IONPs and IONP bound tumor cells with positive contrast and provides contrast enhancement and potential quantification of IONPs in molecular imaging applications.","id":"39878995","pubmedId":"21182139","fileId":null,"fileTitle":null,"editable":false}];
	// checks if keyword results are empty and sets data to non undefined value //
	var data = $scope.keywordData;
	if (data==null) {
		$scope.keywordData = [];
		data = [];
	};

	// gets link and action type of each row for the actions column //
	$scope.getLink = function(row) {
		var view_actions = {};
		var edit_actions = {};
		var actionList = [];

		// check type and set link action and action type
		if (row.type=='sample') {
			view_actions.actionType = 'View';
			view_actions.link = '#/sample?sampleId=' + row.id;
			actionList.push(view_actions);			
			if (row.editable==true) { 		
				edit_actions.link = '#/editSample?sampleId=' + row.id;
				edit_actions.actionType = 'Edit';
				actionList.push(edit_actions);
			}

		}
		else if (row.type=='publication') {
			if (row.pubmedId) {
				view_actions.actionType = "View";
				view_actions.link = 'http://www.ncbi.nlm.nih.gov/pubmed/' + row.pubmedId;
				view_actions.target = '_blank';	
				actionList.push(view_actions);	
			}
			if (row.editable==true) { 	
				edit_actions.link = '#/editPublication?publicationId=' + row.id;
				edit_actions.actionType = 'Edit';
				actionList.push(edit_actions);
			}		

		}
		else {
			if (row.fileId) {
				view_actions.link = '/caNanoLab/rest/protocol/download?fileId=' + row.fileId;
				view_actions.actionType = 'View';
				actionList.push(view_actions);				
			}			
			if (row.editable==true) { 		
				edit_actions.link = '#/editProtocol?protocolId=' + row.id;
				edit_actions.actionType = 'Edit';
				actionList.push(edit_actions);
			}	
		}
		return actionList;
	};

	// setup table for displaying search results //
	$scope.tableParams = new ngTableParams(
		{
			page: 1,            // show first page
			count: 10           // count per page     
		},
		{
			counts: [], // hide page counts control

			total: data.length, // length of data
			getData: function($defer, params) {
			// use build-in angular filter
			var orderedData = params.sorting() ? 
			$filter('orderBy')(data, params.orderBy()) : data;
			$defer.resolve(orderedData.slice((params.page() - 1) * params.count(), params.page() * params.count()));
		} 
	});  

    $scope.openDataAvailability = function(description) {
            var modalInstance = $modal.open({                          
              templateUrl: 'views/publication/view/publicationDescription.html',
              controller: 'PublicationDescriptionCtrl',
              size: 'sm',
              resolve: {
                description: function () {
                  return description;
                }
              }
            });       
    };	

    $scope.addToFavorites = function() {


    }

    $scope.addToFavorites = function(sampleId, sampleName, editable, nanoEntityDesc) {
        $scope.loader = true;
        
        $scope.favoriteBean = {"dataType" : "sample", "dataName" : sampleName, "dataId" : sampleId, "editable" : editable, "description":nanoEntityDesc, "loginName" : $scope.loggedInUser.name};

        $http({method: 'POST', url: '/caNanoLab/rest/core/addFavorite',data: $scope.favoriteBean}).
            success(function(data, status, headers, config) {
                 var hrefEl = document.getElementById('href' + sampleId);
                 var msgEl = document.getElementById('msg' + sampleId);
                 msgEl.innerHTML = data;
                 hrefEl.style.visibility="hidden";
                 $scope.loader = false;

            }).
            error(function(data, status, headers, config) {
                // called asynchronously if an error occurs
                // or server returns response with an error status.
                // $rootScope.sampleData = data;
                $scope.loader = false;
                $scope.messages = data;
            });
    };        

        $scope.addToFavorites = function(protocolId, protocolName, fileId, editable, protocolFileTitle) {
            $scope.loader = true;
            
            $scope.favoriteBean = {"dataType" : "protocol", "dataName" : protocolName, "dataId" : protocolId, "protocolFileId" : fileId, "editable" : editable, "protocolFileTitle":protocolFileTitle, "loginName" : $scope.loggedInUser.name};

            $http({method: 'POST', url: '/caNanoLab/rest/core/addFavorite',data: $scope.favoriteBean}).
                success(function(data, status, headers, config) {
                     var hrefEl = document.getElementById('href' + protocolId);
                     var msgEl = document.getElementById('msg' + protocolId);
                     msgEl.innerHTML = data;
                     hrefEl.style.visibility="hidden";
                     $scope.loader = false;

                }).
                error(function(data, status, headers, config) {
                    // called asynchronously if an error occurs
                    // or server returns response with an error status.
                    // $rootScope.sampleData = data;
                    $scope.loader = false;
                    $scope.messages = data;
                });
        };  

    
    $scope.addToFavorites = function(row) {
    		if (row.type=='sample') {
    			$scope.favoriteBean = {"dataType" : "sample", "dataName" : row.name, "dataId" : row.id, "editable" : row.editable, "description":row.description, "loginName" : $scope.loggedInUser.name};
    		}
    		if (row.type=='publication') {
    			$scope.favoriteBean = {"dataType" : "publication", "dataName" : row.name, "dataId" : row.id, "pubmedId" : row.pubmedId, "editable" : row.editable, "loginName" : $scope.loggedInUser.name};
    		}
    		if (row.type=='protocol') {
    			$scope.favoriteBean = {"dataType" : "protocol", "dataName" : row.name, "dataId" : row.id, "protocolFileId" : row.fileId, "editable" : row.editable, "protocolFileTitle":row.fileTitle, "loginName" : $scope.loggedInUser.name};
    		}    	
	
    			 	// var hrefEl = document.getElementById('href' + row.id);
         //         var msgEl = document.getElementById('msg' + row.id);
         //         msgEl.innerHTML = "ASDASD";
         //         hrefEl.style.visibility="hidden";

        // $scope.loader = true;
        
        // $scope.favoriteBean = {"dataType" : "publication", "dataName" : publicationTitle, "dataId" : publicationId, "pubmedId" : pubmedId, "editable" : editable, "loginName" : $scope.loggedInUser.name};

        $http({method: 'POST', url: '/caNanoLab/rest/core/addFavorite',data: $scope.favoriteBean}).
            success(function(data, status, headers, config) {
            	  row.favoriteAdded = true;
                 $scope.loader = false;

            }).
            error(function(data, status, headers, config) {
                // called asynchronously if an error occurs
                // or server returns response with an error status.
                // $rootScope.sampleData = data;
                $scope.loader = false;
                $scope.messages = data;
            });
    };                  

});


